Ghayathri Jeyakumar

Statistics

Publications

Citations

487

H-Index

Active since

2013

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The Barbara Ann Karmanos Cancer Institute

Wayne State University

Ghayathri Jeyakumar is an author at The University of Texas MD Anderson Cancer Center specializing in immunotherapy, cancer immunotherapy, and immunology.

Publications per year

2013–2017

Publications

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

Jan A. Burger, Michael J. Keating, William G. Wierda et al. · The Lancet Oncology · 2014 · 332 citations

Pharmacy, Immunology, Pharmacology +14

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

Ghayathri Jeyakumar, Seongho Kim, Naresh Bumma et al. · Journal for ImmunoTherapy of Cancer · 2017 · 102 citations · Full text

Life Sciences, Immunology, Oncology +17

Ibrutinib In Combination With Rituximab (iR) Is Well Tolerated and Induces a High Rate Of Durable Remissions In Patients With High-Risk Chronic Lymphocytic Leukemia (CLL): New, Updated Results Of a Phase II Trial In 40 Patients

Jan A. Burger, Michael J. Keating, William G. Wierda et al. · Blood · 2013 · 42 citations

Medicine, Immunology, Pharmacology +13

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang et al. · Journal for ImmunoTherapy of Cancer · 2016 · 11 citations · Full text

Life Sciences, Immunology, Oncology +13

1–4 of 4